Cargando…
MALT1 is required for EGFR induced NF-κB activation and contributes to EGFR-driven lung cancer progression
The transcription factor NF-κB has been implicated in playing a crucial role in the tumorigenesis of many types of human cancers. Although Epidermal Growth Factor Receptor (EGFR) can directly activate NF-κB, the mechanism by which EGFR induces NF-κB activation and the role of NF-κB in EGFR-associate...
Autores principales: | Pan, Deng, Jiang, Changying, Ma, Zhongliang, Blonska, Marzenna, You, M. James, Lin, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4651666/ https://www.ncbi.nlm.nih.gov/pubmed/25982276 http://dx.doi.org/10.1038/onc.2015.146 |
Ejemplares similares
-
NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers
por: Wang, Xiaoyuan, et al.
Publicado: (2018) -
MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR‐induced NF‐κB activation
por: Liu, Xuejiao, et al.
Publicado: (2020) -
The CARMA3-BCL10-MALT1 (CBM) complex contributes to DNA damage-induced NF-κB activation and cell survival
por: Zhang, Shilei, et al.
Publicado: (2017) -
Precision immunointerception of EGFR-driven tumorigenesis for lung cancer prevention
por: Pan, Jing, et al.
Publicado: (2023) -
Metformin Overcomes Acquired Resistance to EGFR TKIs in EGFR-Mutant Lung Cancer via AMPK/ERK/NF-κB Signaling Pathway
por: Li, Ling, et al.
Publicado: (2020)